Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP

Executive Summary

The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5

You may also be interested in...



House Committee Assignments: Little Shake-Up In The New Make-Up

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

House Committee Assignments: Little Shake-Up In The New Make-Up

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

Generic Drug Reform Outlook: Medicare Rx Bill May Be Best Vehicle

The best opportunity to push Waxman/Hatch reforms in the next Congress will likely be in the context of a Medicare prescription drug benefit bill

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel